Logo image of KZIA

KAZIA THERAPEUTICS-SPON ADR (KZIA) Stock Analyst Ratings

NASDAQ:KZIA - Nasdaq - US48669G3039 - ADR - Currency: USD

6.25  -0.52 (-7.68%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to KZIA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 56.36. This target is 801.68% above the current price.
KZIA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KZIA.
In the previous month the buy percentage consensus was at a similar level.
KZIA was analyzed by 7 analysts. More opinions would make the average more meaningful.
KZIA Historical Analyst RatingsKZIA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -53 -48 -43 -38 -33 -28 -23 -18 -13 -8 -3 2 4 6

Price Target & Forecast

Price Low Median Mean High 6.2515.1556.3656.36100.28 - 142.40% 801.68% 801.68% 1,504.40%
KZIA Current Analyst RatingKZIA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-06-11 Maxim Group Maintains Buy -> Buy
2025-02-06 Maxim Group Initiate Buy
2024-07-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-04-11 HC Wainwright & Co. Upgrade Neutral -> Buy
2022-08-02 Maxim Group Downgrade Buy -> Hold
2022-08-02 HC Wainwright & Co. Downgrade Buy -> Neutral
2021-10-14 Maxim Group Initiate Buy